# Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.

> **NCT07464106** · — · RECRUITING · sponsor: **Robert Bosch Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Tricuspid Regurgitation
- Tricuspid Valve Insufficiency
- Cardio-Renal Syndrome
- Frailty

## Interventions

- **PROCEDURE:** Transcatheter edge-to-edge repair (TEER)

## Key facts

- **NCT ID:** NCT07464106
- **Lead sponsor:** Robert Bosch Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-01
- **Primary completion:** 2026-12
- **Final completion:** 2027-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07464106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07464106, "Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07464106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*